Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
early and sustained accumulation of β-amyloid (Aβ) protein in the brain. Current treatments …

Alzheimer'sdisease (AD) is a progressive neurodegenerative disorder, characterized by
senile plaques constituting extracellular deposits of β-amyloid (Aβ) fibrils. Since Aβ …

Recent evidence supports involvement of amylin and the amylin receptor in the
pathogenesis of Alzheimer's disease (AD). We have previously shown that amylin receptor …

Amylin, a gut-brain axis hormone, and amyloid-beta peptides (Aβ), a major component of the
Alzheimer's disease (AD) brain, share several features, including similar β-sheet secondary …

G-protein-coupled receptors (GPCRs) are shown to be involved in Alzheimer's disease (AD)
pathogenesis. However, because GPCRs include a large family of membrane receptors, it is …

Amylin (islet amyloid polypeptide) and amyloid beta protein (Aβ), identified as proteinaceous
deposits within the pancreas of diabetics and the brain of Alzheimer's patients respectively …

Amylin is an important gut-brain axis hormone. Since amylin and amyloid-β peptide (Aβ)
share similar β sheet secondary structure despite not having the same primary sequences …

Amylin (islet amyloid polypeptide) and amyloid-beta (Aβ) protein, which are deposited within
pancreatic islets of diabetics and brains of Alzheimer's patients respectively, share many …

The metabolic peptide hormone amylin, in concert with other metabolic peptides like insulin
and leptin, has an important role in metabolic homeostasis and has been intimately linked to …

Introduction Amylin receptor serves as a portal for the expression of deleterious effects of
amyloid β-protein (Aβ), a key pathologic hallmark of Alzheimer's disease. Previously, we …